Bala, Rebecca D.

HRN: 20-22-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
CEFTAZIDIME 1GM (VIAL)
02/06/2023
02/12/2023
IV
1gm
Q8
Complicated Uti
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes